NGAL: A Sensitive and Early Biomarker for Acute Kidney Injury
October 1, 2022
At QAWaCh Bio, our journey has always been driven by a singular purpose:
to make advanced diagnostics accessible, affordable, and impactful for every patient.
Why We Started
Healthcare systems worldwide continue to face a critical challenge—late detection of diseases. Conditions like acute kidney injury (AKI) often go unnoticed until it’s too late, leading to severe complications and limited treatment windows.
This gap became our mission.
We envisioned a future where early detection is not a privilege but a standard, and where technology bridges the gap between diagnosis and timely care.
Building Meaningful Innovation
At the core of our innovation lies the Q-Plat platform—a breakthrough approach that combines:
- Lateral flow diagnostics
- Smartphone-based quantitative analysis
- Rapid, reliable, and accessible testing
One of our key solutions, InstaNGAL, is a non-invasive, urine-based test that delivers results within minutes—enabling clinicians to act early and improve patient outcomes significantly.
This is not just innovation for innovation’s sake—
it is innovation designed to save time, reduce risk, and improve lives.
From Idea to Impact
Our journey has been strengthened by the unwavering support of Biotechnology Industry Research Assistance Council through its flagship programs:
- BIG (Biotechnology Ignition Grant)
- BIPP (Biotechnology Industry Partnership Programme)
With this support, we have progressed from:
- Early-stage prototyping
➡️ Clinical validation
➡️Commercialisation
This progression reflects not just technological advancement, but also the growing strength of India’s healthcare innovation ecosystem.
The People Behind the Vision
This recognition is shared with my incredible co-founders:
- Mohan Singh
- Kunal Shukla
…and our extended ecosystem of mentors, partners, and institutions including:
- Indian Institute of Technology Bombay
- Society for Innovation and Entrepreneurship IIT Bombay
- Centre for Cellular and Molecular Platforms
Looking Ahead
Being featured in Founder’s Friday is not just a milestone—it is a reminder.
A reminder that there is still much to be done.
At QAWaCh Bio, we remain committed to:
- Expanding our diagnostic solutions across disease areas
- Enhancing accessibility in underserved regions
- Continuously innovating for faster and more precise detection
A Note of Gratitude
We are deeply thankful to Biotechnology Industry Research Assistance Council for recognising our journey and supporting us from the early stages.
This recognition strengthens our resolve to continue building solutions that truly matter.
Moving Forward, Together
As we celebrate this moment, we also look ahead—with excitement, responsibility, and determination.
Because for us, this is just the beginning.
